This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: H. Lundbeck A/s. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Jelena Ivkovic: Innovator in Epilepsy Treatment
Introduction
Jelena Ivkovic is a prominent inventor based in Valby, Denmark. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of epilepsy and seizures. Her innovative work focuses on the development of novel compounds that activate Kv7 potassium channels.
Latest Patents
Jelena Ivkovic holds a patent for "Alcohol derivatives as Kv7 potassium channel openers for use in epilepsy or seizures." This invention provides novel compounds, specifically compounds of Formula I, which are designed to activate Kv7 potassium channels. The patent also includes aspects directed to pharmaceutical compositions comprising these compounds and their uses in treating disorders responsive to Kv7 channel activation. She has 1 patent to her name.
Career Highlights
Jelena is associated with H. Lundbeck A/S, a company known for its focus on brain diseases. Her work at Lundbeck has positioned her as a key player in the development of treatments for neurological disorders.
Collaborations
Throughout her career, Jelena has collaborated with notable colleagues, including Mario Rottländer and Morten Grupe Larsen. These collaborations have further enhanced her research and development efforts in the pharmaceutical industry.
Conclusion
Jelena Ivkovic is a trailblazer in the field of epilepsy treatment, with her innovative patent contributing to advancements in medical science. Her dedication to improving patient outcomes through her research is commendable.